Serum25-hydroxyvitamin D and markers of insulin resistance in a Japanese working population

European Journal of Clinical Nutrition

Volumn 66, Issue 12, 2012, Pages 1323-1328

  Pham, N M ^a   Akter, S ^a   Kurotani, K ^a   Nanri, A ^a   Sato, M ^b   Hayabuchi, H ^c   Yasuda, K ^a   Mizoue, T ^a  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c FUKUOKA WOMEN'S UNIVERSITY   (Japan)

Author keywords

25 hydroxyvitamin D; glucose; insulin; insulin resistance

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; GLUCOSE; INSULIN; 25-HYDROXYVITAMIN D; BIOLOGICAL MARKER; DRUG DERIVATIVE; VITAMIN D;

ADULT; AGED; ALCOHOL CONSUMPTION; ANTHROPOMETRY; ARTICLE; CALCIUM INTAKE; CONFOUNDING VARIABLE; CROSS-SECTIONAL STUDY; DATA ANALYSIS; DIET RESTRICTION; DISEASE ASSOCIATION; EMPLOYEE; FEMALE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HEALTH SURVEY; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; JAPANESE; MAJOR CLINICAL STUDY; MALE; MULTIPLE LINEAR REGRESSION ANALYSIS; QUESTIONNAIRE; SMOKING; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; ASIAN; BLOOD; DIET; JAPAN; MIDDLE AGED; STATISTICAL MODEL;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; CALCIUM, DIETARY; CROSS-SECTIONAL STUDIES; DIET SURVEYS; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; JAPAN; LINEAR MODELS; MALE; MIDDLE AGED; QUESTIONNAIRES; VITAMIN D; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 84870834547     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/ejcn.2012.169     Document Type: Article

References (46)

1. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357: 266-281.
2. Boucher BJ. Vitamin D insufficiency and diabetes risks. Curr Drug Targets 2011; 12: 61-87.
3. Pittas AG, Lau J, Hu FB, Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 2007; 92: 2017-2029.
4. Mitri J, Muraru MD, Pittas AG. Vitamin D and type 2 diabetes: a systematic review. Eur J Clin Nutr 2011; 65: 1005-1015.
5. Scragg R, Sowers M, Bell C. Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care 2004; 27: 2813-2818.
6. Forouhi NG, Luan J, Cooper A, Boucher BJ, Wareham NJ. Baseline serum 25-hydroxyvitamin D is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990-2000. Diabetes 2008; 57: 2619-2625.
7. Liu E, Meigs JB, Pittas AG, McKeown NM, Economos CD, Booth SL et al. Plasma 25-hydroxyvitamin D is associated with markers of the insulin resistant phenotype in nondiabetic adults. J Nutr 2009; 139: 329-334.
8. Lu L, Yu Z, Pan A, Hu FB, Franco OH, Li H et al. Plasma 25-hydroxyvitamin D concentration and metabolic syndrome among middle-aged and elderly Chinese individuals. Diabetes Care 2009; 32: 1278-1283.
9. Zhao G, Ford ES, Li C. Associations of serum concentrations of 25-hydroxyvitamin D and parathyroid hormone with surrogate markers of insulin resistance among US adults without physician-diagnosed diabetes: NHANES, 2003-2006. Diabetes Care 2010; 33: 344-347.
10. Kayaniyil S, Vieth R, Retnakaran R, Knight JA, Qi Y, Gerstein HC et al. Association of vitamin D with insulin resistance and beta-cell dysfunction in subjects at risk for type 2 diabetes. Diabetes Care 2010; 33: 1379-1381.
11. Cheng S, Massaro JM, Fox CS, Larson MG, Keyes MJ, McCabe EL et al. Adiposity, cardiometabolic risk, and vitamin D status: the Framingham Heart Study. Diabetes 2010; 59: 242-248.
12. Pinelli NR, Jaber LA, Brown MB, Herman WH. Serum 25-hydroxy vitamin D and insulin resistance, metabolic syndrome, and glucose intolerance among Arab Americans. Diabetes Care 2010; 33: 1373-1375.
13. Choi HS, Kim KA, Lim CY, Rhee SY, Hwang YC, Kim KM et al. Low serum vitamin D is associated with high risk of diabetes in Korean adults. J Nutr 2011; 141: 1524-1528.
14. Gagnon C, Lu ZX, Magliano DJ, Dunstan DW, Shaw JE, Zimmet PZ et al. Low serum 25-hydroxyvitamin D is associated with increased risk of the development of the metabolic syndrome at five years: results from a national, population-based prospective study (The Australian Diabetes, Obesity and Lifestyle Study: AusDiab). J Clin Endocrinol Metab 2012; 97: 1953-1961.
15. Husemoen LL, Thuesen BH, Fenger M, Jørgensen T, Glümer C, Svensson J et al. Serum 25(OH)D and type 2 diabetes association in a general population: a prospective study. Diabetes Care 2012; 35: 1695-1700.
16. Gannagé-Yared MH, Chedid R, Khalife S, Azzi E, Zoghbi F, Halaby G. Vitamin D in relation to metabolic risk factors, insulin sensitivity and adiponectin in a young Middle-Eastern population. Eur J Endocrinol 2009; 160: 965-971.
17. Gulseth HL, Gjelstad IM, Tierney AC, Lovegrove JA, Defoort C, Blaak EE et al. Serum vitamin D concentration does not predict insulin action or secretion in European subjects with the metabolic syndrome. Diabetes Care 2010; 33: 923-925.
18. Chacko SA, Song Y, Manson JE, Van Horn L, Eaton C, Martin LW et al. Serum 25-hydroxyvitamin D concentrations in relation to cardiometabolic risk factors and metabolic syndrome in postmenopausal women. Am J Clin Nutr 2011; 94: 209-217.
19. Del Gobbo LC, Song Y, Dannenbaum DA, Dewailly E, Egeland GM. Serum 25-hydroxyvitamin D is not associated with insulin resistance or beta cell function in Canadian Cree. J Nutr 2011; 141: 290-295.
20. Wu T, Willett WC, Giovannucci E. Plasma C-peptide is inversely associated with calcium intake in women and with plasma 25-hydroxy vitamin D in men. J Nutr 2009; 139: 547-554.
21. Chan JC, Malik V, Jia W, Kadowaki T, Yajnik CS, Yoon KH et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA 2009; 301: 2129-2140.
22. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care 2004; 27: 1487-1495.
23. Science and Technology Agency. Standard Tables of Food Composition in Japan. 5th revised and enlarged edn (Printing Bureau of the Ministry of Finance: Tokyo, Japan, 2005.
24. Sasaki S. Development and evaluation of dietary assessment methods using biomarkers and diet history questionnaires for individuals (in Japanese). In: Tanaka H (eds) Research for Evaluation Methods of Nutrition and Dietary Lifestyle Programs Held in Healthy Japan 21. Summary report. Ministry of Health, Welfare, and Labor: Tokyo, Japan, 2004, pp 11-44.
25. Ainsworth BE, Haskell WL, Whitt MC, Irwin ML, Swartz AM, Strath SJ et al. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 2000; 32: S498-S516.
26. Fraser A, Williams D, Lawlor DA. Associations of serum 25-hydroxyvitamin D, parathyroid hormone and calcium with cardiovascular risk factors: analysis of 3 NHANES cycles (2001-2006). PLoS One 2010; 5: e13882.
27. Liu E, McKeown NM, Pittas AG, Meigs JB, Economos CD, Booth SL et al. Predicted 25-hydroxyvitamin D score and change in fasting plasma glucose in the Framingham offspring study. Eur J Clin Nutr 2012; 66: 139-141.
28. Chiu KC, Chu A, Go VL, Saad MF. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 2004; 79: 820-825.
29. Higashiguchi M, Onoda T, Turin TC, Sakata K. NIPPON DATA80/90 Research Group. Calcium intake and associated factors in a general Japanese population: baseline data of NIPPON DATA80/90 and the National Nutrition Survey. J Epidemiol 2010; 20(Suppl 3): S549-S556.
30. Nikooyeh B, Neyestani TR, Farvid M, Alavi-Majd H, Houshiarrad A, Kalayi A et al. Daily consumption of vitamin D-or vitamin D\+calcium-fortified yogurt drink improved glycemic control in patients with type 2 diabetes: a randomized clinical trial. Am J Clin Nutr 2011; 93: 764-771.
31. von Hurst PR, Stonehouse W, Coad J. Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient-a randomised, placebo-controlled trial. Br J Nutr 2010; 103: 549-555.
32. Pittas AG, Harris SS, Stark PC, Dawson-Hughes B. The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care 2007; 30: 980-986.
33. de Boer IH, Tinker LF, Connelly S, Curb JD, Howard BV, Kestenbaum B et al. Women's Health Initiative Investigators. Calcium plus vitamin D supplementation and the risk of incident diabetes in the Women's Health Initiative. Diabetes Care 2008; 31: 701-707.
34. Nagpal J, Pande JN, Bhartia A. A double-blind, randomized, placebo-controlled trial of the short-term effect of vitamin D3 supplementation on insulin sensitivity in apparently healthy, middle-aged, centrally obese men. Diabet Med 2009; 26: 19-27.
35. Jorde R, Sneve M, Torjesen P, Figenschau Y. No improvement in cardiovascular risk factors in overweight and obese subjects after supplementation with vitamin D3 for 1 year. J Intern Med 2010; 267: 462-472.
36. Alvarez JA, Bush NC, Choquette SS, Hunter GR, Darnell BE, Oster RA et al. Vitamin D intake is associated with insulin sensitivity in African American, but not European American, women. Nutr Metab (Lond) 2010; 7: 28.
37. Holick MF. Vitamin D and health: evolution, biologic functions, and recommended dietary intakes for vitamin D. Clin Rev Bone Miner Metab 2009; 7: 2-19.
38. Maestro B, Campion J, Davila N, Calle C. Stimulation by 1,25-dihydroxyvitamin D3 of insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells. Endocr J 2000; 47: 383-391.
39. Simpson RU, Thomas GA, Arnold AJ. Identification of 1, 25-dihydroxyvitamin D3 receptors and activities in muscle. J Biol Chem 1985; 260: 8882-8891.
40. Steingrimsdottir L, Gunnarsson O, Indridason OS, Franzson L, Sigurdsson G. Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake. JAMA 2005; 294: 2336-2341.
41. Chiu KC, Chuang LM, Lee NP, Ryu JM, McGullam JL, Tsai GP et al. Insulin sensitivity is inversely correlated with plasma intact parathyroid hormone level. Metabolism 2000; 49: 1501-1505.
42. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000; 72: 690-693.
43. Blum M, Dolnikowski G, Seyoum E, Harris SS, Booth SL, Peterson J et al. Vitamin D-3 in fat tissue. Endocrine 2008; 33: 90-94.
44. Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000; 23: 57-63.
45. Balkau B, Mhamdi L, Oppert JM, Nolan J, Golay A, Porcellati F et al. Physical activity and insulin sensitivity: the RISC study. Diabetes 2008; 57: 2613-2618.
46. Scragg R, Camargo Jr. CA. Frequency of leisure-time physical activity and serum 25-hydroxyvitamin D levels in the US population: results from the Third National Health and Nutrition Examination Survey. Am J Epidemiol 2008; 168: 577-586.